Literature DB >> 14592628

Management of massive calcified transdural thoracic disk herniation.

Mohammed Al-Barbarawi1, Lali H S Sekhon.   

Abstract

Thoracic disk herniation is a not uncommon pathology faced by the spinal surgeon. The management of massive intradural thoracic disk herniation with ventral cord compression is problematic both in terms of obtaining adequate decompression and ensuring no subsequent leakage of cerebrospinal fluid. A 54-year-old woman presented with a 10 year history of back pain and left leg pain. Over the past 6 months she experienced a progressive spastic paraparesis in both legs with recent urinary incontinence. A left anterolateral thoracotomy for excision of T8/9 thoracic disk protrusion was affected. A transdural decompression was performed with resection of the calcified dura and performance of a Gore-Tex duraplasty and pleuroplasty. A free muscle graft was placed in the intervening space and the chest drains were placed on non-suction. A spinal drain was maintained for 5 days. She made an excellent neurological recovery. Avoidance of cerebrospinal leakage is paramount when performing transthoracic approaches as negative intrapleural pressure can lead to persistence of leakage. This report documents a safe and reliable way to deal with massive intradural thoracic disk rupture with avoidance of subsequent spinal fluid leak.

Entities:  

Mesh:

Year:  2003        PMID: 14592628     DOI: 10.1016/j.jocn.2003.02.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Thoracic disc herniation of the adjacent segment with acutely progressing myelopathy.

Authors:  In-Soo Oh; Jun-Yeong Seo; Kee-Yong Ha; Yoon-Chung Kim
Journal:  Asian Spine J       Date:  2010-04-26

2.  Posterior transdural resection of giant calcified thoracic disc herniation in a case series of 12 patients.

Authors:  Chiara Negwer; Vicki M Butenschoen; Sandro M Krieg; Bernhard Meyer
Journal:  Neurosurg Rev       Date:  2020-10-16       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.